Novartis AG announced Friday that its global head of litigation, Thomas Kendris, will on an interim basis succeed its outgoing chief legal officer Shannon Thyme Klinger.
Novartis said in a statement that Klinger will depart the Swiss drug giant March 15 to return to the U.S. and take a job at “a biotechnology company.” Novartis didn’t identify the company and declined to discuss Klinger’s new role. Klinger didn’t respond to a request for comment on the matter.
Her move is the latest in a series of comings-and-goings by law department leaders working for biotechnology startups, drug developers, and ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.